LOS ANGELES CAPITAL MANAGEMENT LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1177206
LOS ANGELES, CA
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$61,471,690
+$525,847 QoQ
Shares Held
98,585
+25.0% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#111
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. REGN ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,471,690 | 98,585 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $60,945,843 | 78,880 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $77,579,109 | 100,508 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $53,604,010 | 95,335 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,889,725 | 7,409 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,924,795 | 7,765 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $374,685 | 526 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,850,182 | 1,760 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,662,258 | 2,533 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,196,375 | 1,243 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $4,694,460 | 5,345 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $576,072 | 700 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $397,352 | 553 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $32,247,260 | 39,246 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $31,942,526 | 44,273 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $37,239,623 | 54,059 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $33,882,980 | 57,319 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $39,233,743 | 56,175 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $70,032,410 | 110,895 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $20,452,058 | 33,795 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $24,685,792 | 44,197 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $12,133,202 | 25,644 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,706,827 | 3,533 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $6,064,096 | 10,833 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $9,717,090 | 15,581 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $12,992,908 | 26,609 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||